Pyxus International (PYYX)
OTHER OTC:PYYX
Want to see PYYX full AI Analyst Report?
Top Page
Pyxus International
(OTC:PYYX)
Select Model
Select Model
Rating:46Neutral
Price Target:
$2.50
▼(-23.31% Downside)
Action:Reiterated
Date:02/24/26
The score is held down primarily by weak financial performance—steep revenue contraction, high leverage, and materially negative operating/free cash flow. Technicals are mixed with neutral momentum but longer-term trend pressure, and valuation is difficult to support due to a negative P/E and no dividend yield provided. The earnings call adds modest support through reaffirmed guidance and liquidity strength, but near-term working-capital and Q4 execution risks remain significant.
Positive Factors
Adjusted EBITDA stability & guidance
Management's reaffirmation and steady adjusted EBITDA (Q3 $80M; YTD $164.2M) indicate recurring operating profitability drivers and clearer near-term cash generation expectations. That stability supports planning, reduces execution uncertainty, and underpins medium-term financial recovery if seasonal conversion occurs.
Negative Factors
Very high leverage
Extremely elevated leverage (multiple turns of debt over equity) constrains strategic flexibility, raises refinancing and covenant risk, and magnifies earnings volatility from interest expense. Over 2–6 months, high leverage limits ability to absorb seasonal shocks and increases dependence on successful inventory conversion.
Read all positive and negative factors
Positive Factors
Negative Factors
Adjusted EBITDA stability & guidance
Management's reaffirmation and steady adjusted EBITDA (Q3 $80M; YTD $164.2M) indicate recurring operating profitability drivers and clearer near-term cash generation expectations. That stability supports planning, reduces execution uncertainty, and underpins medium-term financial recovery if seasonal conversion occurs.
Read all positive factors
Pyxus International (PYYX) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$59.30M
Dividend YieldN/A
Average Volume (3M)3.30K
Price to Earnings (P/E)1.3
Beta (1Y)-0.14
Revenue Growth-6.07%
EPS Growth-152.12%
CountryUS
Employees3,000
SectorConsumer Defensive
Sector Strength42
IndustryTobacco
Share Statistics
EPS (TTM)-0.20
Shares Outstanding24,607,792
10 Day Avg. Volume3,410
30 Day Avg. Volume3,300
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.64
Price to Sales (P/S)0.04
P/FCF Ratio-2.82
Enterprise Value/Market Cap21.33
Enterprise Value/Revenue0.57
Enterprise Value/Gross Profit3.96
Enterprise Value/Ebitda7.78
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Pyxus International Business Overview & Revenue Model
Company Description
Pyxus International, Inc., an agricultural company, engages in the provision of value-added products and services to businesses and customers. It also involved in the purchasing, processing, packing, storing, and shipping tobacco to manufacturers ...
How the Company Makes Money
null...
Pyxus International Earnings Call Summary
Earnings Call Date:Feb 11, 2026
(Q3-2026)
| % Change Since: |
Next Earnings Date:Jun 16, 2026
Earnings Call Sentiment Neutral
The call presented a mix of solid operational execution and near-term financial headwinds. Positives included stable adjusted EBITDA, improved gross margin percentage, meaningful third‑party processing margins, SG&A reductions, a strong liquidity position (undrawn ABL and $130M cash), and material sustainability achievements. Offsetting these positives were a sizable inventory build ($207M), higher working capital needs that drove a 184‑day operating cycle, a use of cash in adjusted free cash flow of $186M, elevated net interest expense, and reliance on concentrated Q4 shipments (with execution risks, particularly in Africa). Management expects Q4 shipments to convert inventory to cash and improve leverage and coverage, and they reaffirmed full-year guidance. Overall, highlights and lowlights are balanced: the company demonstrates operational strength and clear plans to address seasonal liquidity pressures, but near-term working capital and execution risks weigh on the outlook.Positive Updates
Adjusted EBITDA Stability and Full-Year Guidance Reaffirmed
Adjusted EBITDA of $80.0M in Q3 was essentially consistent with prior year (record third quarter last year). Year-to-date adjusted EBITDA was $164.2M, broadly in line with last year. Management reaffirmed full-year fiscal 2026 guidance of $2.4B–$2.6B in net sales and $215M–$235M of adjusted EBITDA.
Negative Updates
Quarter and Year-to-Date Net Sales Decline
Net sales for Q3 were $655.8M, a decrease of approximately $123M versus prior year. Year-to-date net sales totaled $1.7B, down about $245M versus last year, driven primarily by lower average sales prices and shipment timing.
Read all updates
Q3-2026 Updates
Positive
Negative
Adjusted EBITDA Stability and Full-Year Guidance Reaffirmed
Adjusted EBITDA of $80.0M in Q3 was essentially consistent with prior year (record third quarter last year). Year-to-date adjusted EBITDA was $164.2M, broadly in line with last year. Management reaffirmed full-year fiscal 2026 guidance of $2.4B–$2.6B in net sales and $215M–$235M of adjusted EBITDA.
Read all positive updates
Company Guidance
Pyxus reaffirmed fiscal 2026 guidance of $2.4–$2.6 billion in net sales and $215–$235 million of adjusted EBITDA, supported by Q3 adjusted EBITDA of $80 million and year-to-date adjusted EBITDA of $164.2 million (Q3 net sales $655.8 million; YTD sales $1.7 billion), gross margin per kilo of $0.80 in Q3 ($0.81 YTD) and gross margin percentages of 15.2% (Q3) and 14.6% (YTD), plus contributions from third‑party processing of ~$7 million in Q3 and $28.8 million YTD; management expects Q4 peak shipments to convert elevated inventory (Y/Y increase $207 million; uncommitted inventory 3.6% of processed inventory) into cash, materially reduce seasonal borrowings, improve the 184‑day operating cycle, lower leverage (currently ~6 turns) and raise interest coverage (currently ~1.4x), and thereby improve adjusted free cash flow (latest 12‑month adjusted free cash flow was a $186 million use, including $181 million from working‑capital changes); liquidity remains strong with no borrowings on the $150 million ABL and $130 million of cash.Pyxus International Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
22
Negative
Cash Flow
14
Very Negative
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.24B | 2.48B | 2.03B | 1.91B | 1.64B | 1.33B |
| Gross Profit | 319.07M | 342.98M | 312.33M | 261.02M | 227.06M | 151.46M |
| EBITDA | 162.53M | 181.83M | 160.18M | 117.20M | 97.57M | 6.10M |
| Net Income | -4.95M | 15.17M | 2.66M | -56.75M | -92.00M | -117.65M |
Balance Sheet | ||||||
| Total Assets | 1.92B | 1.50B | 1.66B | 1.58B | 1.70B | 1.54B |
| Cash, Cash Equivalents and Short-Term Investments | 129.84M | 78.25M | 92.57M | 136.73M | 198.78M | 92.70M |
| Total Debt | 1.34B | 877.99M | 1.05B | 1.04B | 1.10B | 964.57M |
| Total Liabilities | 1.75B | 1.34B | 1.51B | 1.44B | 1.52B | 1.29B |
| Stockholders Equity | 161.25M | 160.09M | 142.28M | 137.85M | 175.28M | 247.67M |
Cash Flow | ||||||
| Free Cash Flow | -383.96M | -36.41M | -236.01M | -154.13M | -213.59M | -250.92M |
| Operating Cash Flow | -360.27M | -13.39M | -214.97M | -137.82M | -198.76M | -226.54M |
| Investing Cash Flow | 181.92M | 170.64M | 159.45M | 154.94M | 181.24M | 133.48M |
| Financing Cash Flow | 204.61M | -167.26M | 25.56M | -83.00M | 123.26M | 14.35M |
Pyxus International Technical Analysis
Negative
3.26
Price Trends
2.79
Negative
2.93
Negative
3.18
Negative
Market Momentum
-0.11
Positive
39.44
Neutral
14.99
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PYYX, the sentiment is Negative. The current price of 3.26 is above the 20-day moving average (MA) of 2.72, above the 50-day MA of 2.79, and above the 200-day MA of 3.18, indicating a bearish trend. The MACD of -0.11 indicates Positive momentum. The RSI at 39.44 is Neutral, neither overbought nor oversold. The STOCH value of 14.99 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PYYX.
Pyxus International Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $293.99B | 26.50 | -105.29% | 3.59% | 8.48% | 45.92% | |
71 Outperform | $123.10B | 12.64 | -255.35% | 7.02% | 0.75% | -19.96% | |
69 Neutral | $142.63B | 7.23 | 16.33% | 5.22% | 2.16% | 171.90% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | $1.73B | 35.73 | 17.29% | 0.28% | 16.10% | 26.07% | |
56 Neutral | $1.36B | 9.94 | 5.81% | 6.15% | -3.46% | -32.63% | |
46 Neutral | $59.30M | 1.35 | -3.22% | ― | -6.07% | -152.12% |
* Consumer Defensive Sector Average
PYYX
Pyxus International
2.41
-2.09
-46.44%
MO
Altria Group
73.33
17.79
32.03%
BTI
British American Tobacco
65.30
23.40
55.86%
PM
Philip Morris
188.63
19.97
11.84%
UVV
Universal
54.79
0.02
0.04%
TPB
Turning Point Brands
91.20
18.35
25.18%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.